CR20200213A - Modulators of the integrated stress pathway - Google Patents
Modulators of the integrated stress pathwayInfo
- Publication number
- CR20200213A CR20200213A CR20200213A CR20200213A CR20200213A CR 20200213 A CR20200213 A CR 20200213A CR 20200213 A CR20200213 A CR 20200213A CR 20200213 A CR20200213 A CR 20200213A CR 20200213 A CR20200213 A CR 20200213A
- Authority
- CR
- Costa Rica
- Prior art keywords
- modulators
- integrated stress
- stress pathway
- integrated
- pathway
- Prior art date
Links
- 230000009211 stress pathway Effects 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003938 response to stress Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
<p>Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.</p>
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762580742P | 2017-11-02 | 2017-11-02 | |
| US201862463063P | 2018-03-14 | 2018-03-14 | |
| PCT/US2018/058957 WO2019090076A1 (en) | 2017-11-02 | 2018-11-02 | Modulators of the integrated stress pathway |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR20200213A true CR20200213A (en) | 2021-02-16 |
Family
ID=75639556
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR20200213A CR20200213A (en) | 2017-11-02 | 2018-11-02 | Modulators of the integrated stress pathway |
Country Status (1)
| Country | Link |
|---|---|
| CR (1) | CR20200213A (en) |
-
2018
- 2018-11-02 CR CR20200213A patent/CR20200213A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12020550523A1 (en) | Modulators of the integrated stress pathway | |
| PH12020550524A1 (en) | Modulators of the integrated stress pathway | |
| MX2023009561A (en) | Prodrug modulators of the integrated stress pathway. | |
| PH12018502329B1 (en) | Modulators of the integrated stress pathway | |
| AU2017261336A1 (en) | Modulators of the integrated stress pathway | |
| WO2019090085A8 (en) | Modulators of the integrated stress pathway | |
| AU2017260374A1 (en) | Modulators of the integrated stress pathway | |
| PH12021552759A1 (en) | Substituted cycloalkyls as modulators of the integrated stress pathway | |
| MX2020004557A (en) | Modulators of the integrated stress pathway. | |
| MX2020004537A (en) | Modulators of the integrated stress pathway. | |
| MX2020004556A (en) | Modulators of the integrated stress pathway. | |
| MX2020004538A (en) | Modulators of the integrated stress pathway. | |
| MX2020004534A (en) | Modulators of the integrated stress pathway. | |
| DOP2021000151A (en) | INTEGRATED STRESS PATHWAY MODULATORS | |
| EA202091111A1 (en) | INTEGRATED STRESS MODULATORS | |
| MX2016011730A (en) | Compounds for eradicating or inhibiting proliferation of cancer stem cells. |